We are the leading marketplace for scientific research. We exist to make scientific research faster, more effective, and more accessible to researchers everywhere.
When we founded Science Exchange in 2011, we set out to democratize access to the world’s scientific expertise, in order to move the research world forward at a faster pace. Our mission, then and now, is to enable breakthrough scientific discoveries by making it easy for researchers to access the world’s leading scientific service providers and most innovative scientific technologies. To date, Science Exchange has helped tens of thousands of researchers from every scientific discipline imaginable, from Agrologists through to Zymologists, move their research, and by extension humanity, forward… and we’re just getting started.
Co-founder & CEO
Co-founder & COO
John A. Wagner, MD, PhD is Senior Vice President and Head of Translational Research and Early Clinical at Takeda Pharmaceuticals International Co. He is also Editor-in-Chief, Clinical and Translational Science (Wiley), member of the National Academy of Medicine Forum on Drug Discovery, Development, and Translation, Executive Committee member of the FNIH Biomarkers Consortium, and Governance Committee member of Open Targets. Dr. Wagner received his M.D. from Stanford University School of Medicine and Ph.D. from the Johns Hopkins University School of Medicine. Postgraduate training included Internal Medicine Internship and Residency, as well as Molecular and Clinical Pharmacology Postdoctoral Fellowships at Stanford.
Previously, Dr. Wagner’s professional positions included Senior Consultant to the Institute of Medicine, Vice President and Head, Early Development Pipeline and Projects and Head, Global Project Management at Merck & Co., Inc., Vice President and Head, Clinical Pharmacology, at Merck & Co., Inc and Acting Modeling and Simulation Integrator, Strategically Integrated Modeling and Simulation at Merck & Co., Inc. He was also President, the American Society for Clinical Pharmacology and Therapeutics (ASCPT), past chair of the PhRMA Clinical Pharmacology Technical Group, past chair of the adiponectin work group for the FNIH Biomarkers Consortium, past committee member of the National Academy of Medicine Forum on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, and past member of the National Academy of Medicine Forum National Cancer Policy Forum.
He has authored over 230 peer-reviewed publications across a variety of therapeutic areas and disciplines.
Walter Charles is the Chief Procurement Officer at Biogen. Walter is a sought-after speaker at national and international Supply Chain and Procurement Conferences, a visionary Supply Chain leader, an impactful results deliverer and an inspiring Procurement Futurist.
At Biogen, his global procurement teams support the purchase of billions of dollars a year of products and services supporting Research & Development, Manufacturing, Marketing, Legal, Capital, IT, Plant Operations, Travel, and General and Administrative services for the $11B revenue/year biotechnology innovator.
Prior to joining Biogen, Walter has held Chief Procurement Officer roles at iconic companies such as Kraft Foods, Kellogg’s, Johnson & Johnson Consumer Supply Chain and Cordis (one of J&J’s former medical devices companies). As such, he has the unique perspective of serving on Supply Chain Leadership Teams, and leading procurement transformations across Biotechnology, Consumer Packaged Goods, Pharmaceutical and Medical Device Businesses.
Walter holds a Master of Business Administration degree from Columbia University; a Master of Engineering Degree in Environmental Engineering from The Stevens Institute of Technology; and a Bachelor’s of Science Degree from the United States Merchant Marine Academy.